GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). حسب Sangeetha Muthamilselvan (8966006)

"…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…"

Higher reward decreases three measures of response variability. حسب Zvi N. Roth (9611598)

Species richness decreases significantly with increasing percent disturbance. حسب Catherine L. Cardelús (6429320)

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF حسب Britta Hanssen (4898155)

"…Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. …"

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx حسب Britta Hanssen (4898155)

"…Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. …"

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx حسب Britta Hanssen (4898155)

"…Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. …"

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx حسب Britta Hanssen (4898155)

"…Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. …"

Data_Sheet_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx حسب Britta Hanssen (4898155)

"…Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. …"

Data_Sheet_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx حسب Britta Hanssen (4898155)

"…Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. …"

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. حسب Molly B. El Alam (10231830)

Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. حسب Pranjali Beri (14945400)

"…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …"

Metformin/rifampicin combination decreases <i>S</i>. <i>aureus</i> load and persisters in Mice. حسب Xiao-Qi Lin (9548375)

Vibriocidal activities were significantly decreased by depletion of IgM in serum. حسب Jae Seung Yang (701319)

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. حسب Xiang-Fan Chen (13932983)

County-level geographical septile distribution for the first 12 statistically significant factors with at least one statistically significant coefficient ranked by decreasing ΔIC. حسب Yanan Long (11784717)

The size effects for each variable as the coefficient decrease to zero with increasing lambda. حسب Chulyoung Cho (18397361)

Compressed sensing decoded pooled testing significantly decreases the number of tests required to identify infected samples. حسب Kody A. Waldstein (14002708)

Overexpression of Gαq decreases cell number and cell size. حسب Dharsan K. Soundarrajan (11632145)

"…Overexpression of Gαq in the pouch results in a decrease in total wing area, cell number and cell size. 10 samples were analyzed per condition. …"

<i>eIF2A</i> overexpression decreases the cell wall protein levels. حسب Laura Meyer (4033793)

Average effect size decreased as sample size increased for all types of analyses (<i>p</i> < .001). حسب Luke J. Ney (12621627)